Compare ADMA & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | LEU |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.2B |
| IPO Year | N/A | 1998 |
| Metric | ADMA | LEU |
|---|---|---|
| Price | $19.49 | $261.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $28.50 | ★ $243.00 |
| AVG Volume (30 Days) | ★ 2.8M | 883.6K |
| Earning Date | 11-05-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 205.35 | 31.25 |
| EPS | 0.86 | ★ 6.17 |
| Revenue | ★ $488,559,000.00 | $454,100,000.00 |
| Revenue This Year | $22.19 | $1.17 |
| Revenue Next Year | $24.33 | $8.96 |
| P/E Ratio | ★ $23.22 | $42.33 |
| Revenue Growth | ★ 27.63 | 15.25 |
| 52 Week Low | $13.50 | $49.40 |
| 52 Week High | $25.67 | $464.25 |
| Indicator | ADMA | LEU |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 49.07 |
| Support Level | $18.33 | $220.50 |
| Resistance Level | $19.94 | $281.33 |
| Average True Range (ATR) | 0.66 | 20.52 |
| MACD | -0.16 | 2.88 |
| Stochastic Oscillator | 56.86 | 58.88 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.